Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular Disease
Authors:
- Darin T RosenDRDarin T Rosen
- Todd M KolbTKTodd M Kolb
- Stephen C MathaiSMStephen C Mathai
- Karthik SureshKSKarthik Suresh
- Steven HsuSHSteven Hsu
- Ryan J TedfordRTRyan J Tedford
- Anna R HemnesAHAnna R Hemnes
- Jane A LeopoldJane A Leopold
- Evelyn M HornEHEvelyn M Horn
- Erika S Berman-RosenzweigEBErika S Berman-Rosenzweig
- Franz RischardFRFranz Rischard
Open Access
- 3 June 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (11) , e041127
Abstract
Background: Right ventricular (RV) maladaptation to elevated pulmonary afterload is the primary determinant of outcomes in pulmonary artery (PA) hypertension; however, the pathobiological mechanisms underlying RV decompensation remain poorly understood. Methods: We performed global untargeted metabolomics on plasma from 55 patients who underwent gold‐standard RV‐PA coupling measurements using multibeat pressure volume loop assessment in a single‐center cohort and from 1027 patients with coupling surrogate measurements in a larger multicenter cohort, the PVDOMICS (Pulmonary Vascular Disease Phenomics) study. Age and sex‐adjusted linear regression was performed to identify associations between metabolites and coupling metrics. Additionally, we performed a metabolic flux analysis using gene expression data from RV tissue in an independent cohort of 32 patients. Partial least squares–discriminant analysis was used to identify metabolites and reactions characteristic of the decompensated RV. Results: RV‐PA coupling was negatively associated with tricarboxylic acid (TCA) cycle intermediate levels. Specifically, plasma α‐ketoglutarate and fumarate were significantly associated with all coupling metrics in both cohorts. Metabolic flux analysis indicated that decompensated RVs exhibited aberrant TCA cycle activity, including reduced acetyl coenzyme A entry and increased lactate elimination, suggesting a shift from the TCA cycle toward glycolysis at the RV tissue level. Conclusions: We identify an association between circulating TCA cycle intermediate levels and RV‐PA uncoupling in 2 independent cohorts, and dysregulated TCA cycle metabolism in decompensated PA hypertension RVs, suggesting that aberrant TCA cycle metabolism could represent a hallmark of RV maladaptation in PA hypertension. Further study of this pathway is warranted to develop novel biomarkers of RV function or RV‐targeted therapies.Keywords
This publication has 46 references indexed in Scilit:
- Metabolomic Differences in Connective Tissue Disease–Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS CohortArthritis & Rheumatology, 2023
- l‐Carnitine therapy improves right heart dysfunction through Cpt1‐dependent fatty acid oxidationPulmonary Circulation, 2022
- Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failureMetabolism, 2021
- Integrative proteomics and phosphoproteomics in pulmonary arterial hypertensionScientific Reports, 2019
- Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertensionInternational Journal of Cardiology, 2018
- Imaging right ventricular function to predict outcome in pulmonary arterial hypertensionInternational Journal of Cardiology, 2016
- Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary HypertensionJACC, 2016
- Increased [18F]Fluorodeoxyglucose Accumulation in Right Ventricular Free Wall in Patients With Pulmonary Hypertension and the Effect of EpoprostenolJACC, 2005
- Partial least squares for discriminationJournal of Chemometrics, 2003
- Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventionsCardiovascular Research, 1997